Aspect Biosystems
Developing Bioprinted Tissue Therapeutics to transform how we treat some of the most elusive diseases.
143 employees · est. 2013 · Canada
Fluicell
Making tissue therapeutics possible to defeat serious disease
16 employees · est. 2012 · Sweden
Fluicell is the older company (2013 vs 2012); Aspect Biosystems is the larger of the two.
2 signals in the last 90 days
Side-by-Side Comparison
| Metric | Aspect Biosystems | Fluicell |
|---|---|---|
| Founded | ||
| Founded | 2013 | 2012 older |
| Headquarters | ||
| Headquarters | Canada | Sweden |
| Employees | ||
| Employees | 143 larger | 16 |
| Industry | ||
| Industry | Biotechnology, Life Sciences | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Unknown | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $323.73M | $4.00M |
| Funding Rounds | ||
| Funding Rounds | 15 | 2 |
| Services | ||
| Services | Development of Bioprinted Tissue Therapeutics, Regenerative Medicine Solutions, Cutting-edge Biotech Collaborations | Not tracked yet |
| Target Customers | ||
| Target Customers | Pharmaceutical Companies, Biotechnology Firms, Healthcare Providers focused on Metabolic and Endocrine Conditions, Research Institutions seeking advanced tissue therapies | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Bioprinted Tissue Therapeutics, Cellular Medicines, Regenerative Medicine, AI-Powered Bioprinting, Hypoimmune Cell Engineering, Advanced Biomaterials, Endocrine Diseases, Metabolic Disorders, 3D Bioprinting Technology, Allogeneic Cell Therapy, Organ Function Restoration, Rare Endocrine Disorders, Diabetes Treatment, Tissue Therapeutic Platform, Partnerships In Biotech | Regenerative Medicine, Drug Screening, Tissue Therapeutics, Bioprinting, Microfluidics, Biomedicine, Single-Cell Biology, Single-Cell Pharmacology, Cell Therapy, Diabetes, Precision Engineering, Transplantable Tissues, Patent-Protected R&D |
| Website | ||
| Website | aspectbiosystems.com | fluicell.com |
About Aspect Biosystems
Aspect Biosystems is a pioneering force in the biotechnology landscape, focusing on bioprinted tissue therapeutics that promise to transform treatments for particularly elusive diseases. Their full-stack tissue therapeutic platform leverages proprietary AI-powered bioprinting technology, therapeutic...
About Fluicell
Fluicell is a Swedish biotechnology startup dedicated to revolutionizing disease treatment through innovative tissue solutions for regenerative medicine and drug screening. The company's groundbreaking Nexocyte platform, developed over two decades of disruptive R&D, introduces novel approaches to co...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Aspect Biosystems and Fluicell — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Aspect Biosystems and Fluicell — by email.
Frequently Asked Questions
Compare Aspect Biosystems with someone else
Start typing a company name or domain.